BioAge Labs Inc Sustainability Reports
BioAge Labs, Inc. is a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biological mechanisms that drive human aging.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900NG0C40250Z7875
FIGI: BBG00HBTB0N8
1 reports from 2024 to 2024
